Publicaciones en colaboración con investigadores/as de Hospital Arnau de Vilanova (59)

2024

  1. Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale

    Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 10, Núm. 2

  2. Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis

    Patient Preference and Adherence , Vol. 18, pp. 1163-1171

  3. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

    Blood, Vol. 144, Núm. 6, pp. 646-656

  4. Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease

    Annals of Hematology

  5. Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis

    Leukemia

  6. Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis

    HemaSphere

  7. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study

    Movement Disorders Clinical Practice, Vol. 11, Núm. 7, pp. 830-849

  8. Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 91

  9. Repercussion of psoriasis on the emotional health, well-being and quality of life of patients: A descriptive cross-sectional study

    Piel, Vol. 39, Núm. 4, pp. 185-192

  10. Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)

    Revista Espanola de Cardiologia, Vol. 77, Núm. 11, pp. 936-946

  11. The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

    Journal of Gastroenterology, Vol. 59, Núm. 7, pp. 586-597

  12. The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis

    American Journal of Hematology

  13. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain

    Annals of Hematology, Vol. 102, Núm. 2, pp. 447-456

  2. Results in mediastinal lymph node staging of surgical lung cancer: Data from the prospective cohort of the Spanish Video-Assisted Thoracic Surgery Group

    Cirugia Espanola, Vol. 101, Núm. 6, pp. 408-416

2022

  1. ANTES Program: One Year on

    Archivos de Bronconeumologia

  2. Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

    Neurologia, Vol. 37, Núm. 8, pp. 615-630

  3. Incidence, Clinical Characteristics, Risk Factors and Outcomes of Acute Coronary Syndrome in Patients With COVID-19: Results of the UMC-19-S1010

    Journal of Emergency Medicine, Vol. 62, Núm. 4, pp. 443-454

  4. Respiratory symptoms and their determinants in the general Spanish population: changes over 20 years

    ERJ Open Research, Vol. 8, Núm. 4

  5. Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update

    Archivos de Bronconeumologia, Vol. 58, Núm. 4, pp. 345-351